PRWeek recognizes Crisp, and its founder and CEO Adam Hildreth, as part of the Dashboard 25: Class of 2021. Read more
Corporate Governance
We partner with Board Members and C-suite executives to defend their corporate reputations, helping them to mitigate risks that emerge online before they damage business operations and market value.
Brand Communications
We partner with Brand Communications visionaries charged with defending the brand reputation of their enterprises, enabling them to rapidly respond to damaging incidents and issues before they become a full-blown crisis.
Digital Marketing
We partner with digital marketing teams to deliver world-class monitoring and moderation of social media pages and social advertising campaigns, protecting them from harmful content and bad actors intent on disrupting consumer engagement.
Regulatory Compliance
We partner with compliance teams to ensure social media activities meet their regulatory obligations, preventing internally and publicly-generated content from violating industry standards for legal and appropriate online engagement.
Pharmacovigilance and Drug Safety
We partner with pharmacovigilance and drug safety teams to keep their social media presence safe and compliant, detecting potential Adverse Events on brand-sponsored social media pages, advertisements and social listening platforms.
Corporate Security
We partner with corporate security teams, empowering them to identify and rapidly respond to online threats made against company executives, employees, assets and public events.
Platform Trust and Safety
We partner with trust and safety teams to ensure they are the first to know about new online harms before they reach their platforms, defending the integrity of their channels and ensuring the safest online experience for users.
Crisp Blog
Now that the COVID-19 vaccines are being distributed globally, there is a light at the end of the tunnel. A light that, while signaling a return to some sort of normalcy by year’s end, has put pharma companies in the public eye like no other time in recent memory. They are not only confronted with a complex environment of meticulous oversight of industry and government regulators but also a more complicated social media landscape.
It seems no good deed goes unpunished on social media.
Social media use is exploding, and the pharmaceutical industry could be in for a major headache.
With COVID-19 vaccines now in distribution, pharma brands are on high alert as they anticipate a surge of misinformation on social media.
As of July 2020, the number of global internet users has grown to 4.8 billion, which is more than half the world’s population. At the same time, digital advertising in pharma is expected to increase to a projected $10 billion for the year. This is because consumers are spending more time engaging with health content than content from any other industry, including news, finance, and travel—and are using social media to find it.
